Drug recall · October 2, 2019
Natpara recall
Why: Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Natpara (parathyroid hormone) for Injection, 100 mcg, 2 pack medication cartridges, Rx only, For subcutaneous use only, Manufactured for: Shire-NPS Pharmaceuticals, Inc., Lexington, MA 68875-0205-02
- Lots / codes
06828752, exp 12/31/2019 07110118, exp 4/30/2021 07164107, exp 12/31/2019 07200436, 07301074, exp 4/30/2021 07482212, 07630715, exp 6/30/2021 07769460, exp 4/30/2021
- Quantity
- 8,003
- Company
- Shire Human Genetic Therapies, Inc., Lexington, MA
- Distribution
- Product was distributed throughout the United States.
- Initiated
- September 12, 2019 · Voluntary: Firm initiated
- Classified
- October 1, 2019
- Reported
- October 2, 2019
- Ended
- March 23, 2021
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.